nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—CYP2C19—prostate cancer	0.102	0.611	CbGaD
Glyburide—CYP3A4—prostate cancer	0.0648	0.389	CbGaD
Glyburide—SLCO2B1—Estrone—prostate cancer	0.0312	0.057	CbGbCtD
Glyburide—ABCC1—Abiraterone—prostate cancer	0.0265	0.0484	CbGbCtD
Glyburide—ABCB11—Ethinyl Estradiol—prostate cancer	0.0241	0.0439	CbGbCtD
Glyburide—ABCC3—Conjugated Estrogens—prostate cancer	0.0204	0.0373	CbGbCtD
Glyburide—SLCO2B1—Conjugated Estrogens—prostate cancer	0.0204	0.0373	CbGbCtD
Glyburide—SLCO2B1—Estradiol—prostate cancer	0.0179	0.0327	CbGbCtD
Glyburide—SLCO1A2—Estrone—prostate cancer	0.0171	0.0313	CbGbCtD
Glyburide—CFTR—vas deferens—prostate cancer	0.0156	0.244	CbGeAlD
Glyburide—ABCG2—Cabazitaxel—prostate cancer	0.0131	0.024	CbGbCtD
Glyburide—ABCG2—Estrone—prostate cancer	0.0128	0.0234	CbGbCtD
Glyburide—ABCC2—Ethinyl Estradiol—prostate cancer	0.0127	0.0231	CbGbCtD
Glyburide—ABCC1—Conjugated Estrogens—prostate cancer	0.0126	0.0229	CbGbCtD
Glyburide—ALB—Abiraterone—prostate cancer	0.0122	0.0223	CbGbCtD
Glyburide—ABCC3—Etoposide—prostate cancer	0.0117	0.0214	CbGbCtD
Glyburide—ABCC1—Mitoxantrone—prostate cancer	0.0114	0.0208	CbGbCtD
Glyburide—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0112	0.0204	CbGbCtD
Glyburide—SLCO1A2—Estradiol—prostate cancer	0.00984	0.018	CbGbCtD
Glyburide—CYP2C19—Nilutamide—prostate cancer	0.00958	0.0175	CbGbCtD
Glyburide—CYP2C19—Bicalutamide—prostate cancer	0.00958	0.0175	CbGbCtD
Glyburide—ABCC2—Conjugated Estrogens—prostate cancer	0.00929	0.017	CbGbCtD
Glyburide—ABCC1—Epirubicin—prostate cancer	0.00923	0.0168	CbGbCtD
Glyburide—ALB—Estrone—prostate cancer	0.00885	0.0161	CbGbCtD
Glyburide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00881	0.0161	CbGbCtD
Glyburide—SLCO1A2—Prednisone—prostate cancer	0.00846	0.0154	CbGbCtD
Glyburide—ABCG2—Conjugated Estrogens—prostate cancer	0.0084	0.0153	CbGbCtD
Glyburide—SLC22A7—Docetaxel—prostate cancer	0.00838	0.0153	CbGbCtD
Glyburide—ABCC3—Doxorubicin—prostate cancer	0.00799	0.0146	CbGbCtD
Glyburide—CYP2C9—Bicalutamide—prostate cancer	0.00796	0.0145	CbGbCtD
Glyburide—CYP2C9—Nilutamide—prostate cancer	0.00796	0.0145	CbGbCtD
Glyburide—CYP2C19—Flutamide—prostate cancer	0.00794	0.0145	CbGbCtD
Glyburide—ABCG2—Mitoxantrone—prostate cancer	0.00764	0.0139	CbGbCtD
Glyburide—ABCG2—Estradiol—prostate cancer	0.00737	0.0135	CbGbCtD
Glyburide—ABCC1—Etoposide—prostate cancer	0.0072	0.0131	CbGbCtD
Glyburide—ABCB1—Estramustine—prostate cancer	0.00718	0.0131	CbGbCtD
Glyburide—ABCB11—Doxorubicin—prostate cancer	0.00691	0.0126	CbGbCtD
Glyburide—SLC22A6—Conjugated Estrogens—prostate cancer	0.0068	0.0124	CbGbCtD
Glyburide—ABCC1—Docetaxel—prostate cancer	0.00658	0.012	CbGbCtD
Glyburide—CFTR—semen—prostate cancer	0.00557	0.0869	CbGeAlD
Glyburide—ABCC2—Etoposide—prostate cancer	0.00533	0.00972	CbGbCtD
Glyburide—ALB—Estradiol—prostate cancer	0.00508	0.00927	CbGbCtD
Glyburide—ABCC1—Doxorubicin—prostate cancer	0.00491	0.00895	CbGbCtD
Glyburide—ABCC2—Docetaxel—prostate cancer	0.00487	0.00889	CbGbCtD
Glyburide—ABCG2—Etoposide—prostate cancer	0.00481	0.00879	CbGbCtD
Glyburide—CYP2C9—Estrone—prostate cancer	0.00477	0.0087	CbGbCtD
Glyburide—ABCB1—Cabazitaxel—prostate cancer	0.00474	0.00864	CbGbCtD
Glyburide—CYP3A4—Bicalutamide—prostate cancer	0.00463	0.00845	CbGbCtD
Glyburide—ABCB1—Estrone—prostate cancer	0.00463	0.00845	CbGbCtD
Glyburide—ABCG2—Docetaxel—prostate cancer	0.00441	0.00804	CbGbCtD
Glyburide—ALB—Prednisone—prostate cancer	0.00437	0.00798	CbGbCtD
Glyburide—CYP3A4—Estramustine—prostate cancer	0.0043	0.00785	CbGbCtD
Glyburide—ABCB1—Ethinyl Estradiol—prostate cancer	0.00413	0.00753	CbGbCtD
Glyburide—CYP3A4—Abiraterone—prostate cancer	0.00384	0.007	CbGbCtD
Glyburide—CYP3A4—Flutamide—prostate cancer	0.00384	0.007	CbGbCtD
Glyburide—ABCC8—penis—prostate cancer	0.00364	0.0567	CbGeAlD
Glyburide—ABCC2—Doxorubicin—prostate cancer	0.00363	0.00663	CbGbCtD
Glyburide—CYP2C9—Capecitabine—prostate cancer	0.00362	0.0066	CbGbCtD
Glyburide—CYP2C19—Estradiol—prostate cancer	0.0033	0.00601	CbGbCtD
Glyburide—ABCG2—Doxorubicin—prostate cancer	0.00328	0.00599	CbGbCtD
Glyburide—ABCB1—Conjugated Estrogens—prostate cancer	0.00303	0.00553	CbGbCtD
Glyburide—CYP3A4—Cabazitaxel—prostate cancer	0.00284	0.00518	CbGbCtD
Glyburide—CYP2C19—Prednisone—prostate cancer	0.00283	0.00517	CbGbCtD
Glyburide—CYP3A4—Estrone—prostate cancer	0.00277	0.00506	CbGbCtD
Glyburide—ABCB1—Mitoxantrone—prostate cancer	0.00275	0.00502	CbGbCtD
Glyburide—CYP2C9—Estradiol—prostate cancer	0.00274	0.005	CbGbCtD
Glyburide—ABCB1—Estradiol—prostate cancer	0.00266	0.00485	CbGbCtD
Glyburide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00247	0.00451	CbGbCtD
Glyburide—ABCB1—Prednisone—prostate cancer	0.00229	0.00417	CbGbCtD
Glyburide—ABCC9—prostate gland—prostate cancer	0.00218	0.034	CbGeAlD
Glyburide—CYP3A4—Conjugated Estrogens—prostate cancer	0.00181	0.00331	CbGbCtD
Glyburide—ABCB1—Etoposide—prostate cancer	0.00174	0.00317	CbGbCtD
Glyburide—CYP3A4—Mitoxantrone—prostate cancer	0.00165	0.00301	CbGbCtD
Glyburide—CYP3A4—Estradiol—prostate cancer	0.00159	0.00291	CbGbCtD
Glyburide—ABCB1—Docetaxel—prostate cancer	0.00159	0.0029	CbGbCtD
Glyburide—CPT1A—prostate gland—prostate cancer	0.00159	0.0248	CbGeAlD
Glyburide—ABCA1—prostate gland—prostate cancer	0.00148	0.0231	CbGeAlD
Glyburide—CFTR—prostate gland—prostate cancer	0.0014	0.0218	CbGeAlD
Glyburide—CYP2C19—urine—prostate cancer	0.00139	0.0218	CbGeAlD
Glyburide—CYP3A4—Prednisone—prostate cancer	0.00137	0.0025	CbGbCtD
Glyburide—ABCB1—Doxorubicin—prostate cancer	0.00118	0.00216	CbGbCtD
Glyburide—CFTR—seminal vesicle—prostate cancer	0.00118	0.0184	CbGeAlD
Glyburide—CPT1A—renal system—prostate cancer	0.00108	0.0169	CbGeAlD
Glyburide—CYP2C9—urine—prostate cancer	0.00108	0.0169	CbGeAlD
Glyburide—KCNJ1—renal system—prostate cancer	0.00106	0.0165	CbGeAlD
Glyburide—CYP3A4—Etoposide—prostate cancer	0.00104	0.0019	CbGbCtD
Glyburide—CFTR—epithelium—prostate cancer	0.00103	0.016	CbGeAlD
Glyburide—ABCA1—renal system—prostate cancer	0.00101	0.0157	CbGeAlD
Glyburide—ABCC9—testis—prostate cancer	0.000961	0.015	CbGeAlD
Glyburide—CFTR—renal system—prostate cancer	0.000952	0.0149	CbGeAlD
Glyburide—CYP3A4—Docetaxel—prostate cancer	0.000952	0.00174	CbGbCtD
Glyburide—ABCC8—prostate gland—prostate cancer	0.000868	0.0135	CbGeAlD
Glyburide—CYP3A4—urine—prostate cancer	0.000824	0.0129	CbGeAlD
Glyburide—ABCC8—seminal vesicle—prostate cancer	0.000734	0.0115	CbGeAlD
Glyburide—ABCC3—prostate gland—prostate cancer	0.000729	0.0114	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—prostate cancer	0.000709	0.00129	CbGbCtD
Glyburide—SLC22A7—renal system—prostate cancer	0.000704	0.011	CbGeAlD
Glyburide—CPT1A—testis—prostate cancer	0.000699	0.0109	CbGeAlD
Glyburide—ABCC9—lymph node—prostate cancer	0.000696	0.0109	CbGeAlD
Glyburide—SLCO2B1—prostate gland—prostate cancer	0.00068	0.0106	CbGeAlD
Glyburide—ABCA1—testis—prostate cancer	0.000651	0.0102	CbGeAlD
Glyburide—CFTR—testis—prostate cancer	0.000615	0.0096	CbGeAlD
Glyburide—SLC15A1—epithelium—prostate cancer	0.00061	0.00952	CbGeAlD
Glyburide—ABCC8—renal system—prostate cancer	0.000592	0.00924	CbGeAlD
Glyburide—ABCC2—prostate gland—prostate cancer	0.000583	0.00909	CbGeAlD
Glyburide—SLC15A1—renal system—prostate cancer	0.000566	0.00883	CbGeAlD
Glyburide—SLC15A2—prostate gland—prostate cancer	0.000519	0.0081	CbGeAlD
Glyburide—ABCC1—prostate gland—prostate cancer	0.000513	0.00801	CbGeAlD
Glyburide—Bezafibrate—PPARA—prostate cancer	0.000508	0.214	CrCbGaD
Glyburide—CPT1A—lymph node—prostate cancer	0.000507	0.00791	CbGeAlD
Glyburide—ABCB11—testis—prostate cancer	0.000505	0.00788	CbGeAlD
Glyburide—ABCC3—renal system—prostate cancer	0.000497	0.00775	CbGeAlD
Glyburide—ABCA1—lymph node—prostate cancer	0.000472	0.00737	CbGeAlD
Glyburide—SLCO2B1—renal system—prostate cancer	0.000463	0.00723	CbGeAlD
Glyburide—SLC22A7—testis—prostate cancer	0.000455	0.0071	CbGeAlD
Glyburide—SLC15A2—seminal vesicle—prostate cancer	0.000439	0.00685	CbGeAlD
Glyburide—Gliclazide—VEGFA—prostate cancer	0.000434	0.183	CrCbGaD
Glyburide—ABCC1—seminal vesicle—prostate cancer	0.000434	0.00677	CbGeAlD
Glyburide—SLCO1A2—renal system—prostate cancer	0.000426	0.00665	CbGeAlD
Glyburide—ABCG2—prostate gland—prostate cancer	0.000425	0.00663	CbGeAlD
Glyburide—ABCC2—renal system—prostate cancer	0.000397	0.0062	CbGeAlD
Glyburide—ABCC8—testis—prostate cancer	0.000383	0.00597	CbGeAlD
Glyburide—ABCG2—seminal vesicle—prostate cancer	0.000359	0.00561	CbGeAlD
Glyburide—SLC15A2—renal system—prostate cancer	0.000354	0.00552	CbGeAlD
Glyburide—SLC15A2—urethra—prostate cancer	0.000347	0.00542	CbGeAlD
Glyburide—ABCC1—urethra—prostate cancer	0.000344	0.00536	CbGeAlD
Glyburide—ABCC3—testis—prostate cancer	0.000321	0.00501	CbGeAlD
Glyburide—KCNJ11—lymph node—prostate cancer	0.000301	0.0047	CbGeAlD
Glyburide—SLCO2B1—testis—prostate cancer	0.000299	0.00467	CbGeAlD
Glyburide—ABCG2—urethra—prostate cancer	0.000284	0.00444	CbGeAlD
Glyburide—SLCO1A2—testis—prostate cancer	0.000276	0.0043	CbGeAlD
Glyburide—ALB—testis—prostate cancer	0.000274	0.00427	CbGeAlD
Glyburide—ABCC2—testis—prostate cancer	0.000257	0.004	CbGeAlD
Glyburide—Zafirlukast—CYP2E1—prostate cancer	0.000247	0.104	CrCbGaD
Glyburide—Zafirlukast—CYP2C19—prostate cancer	0.000244	0.103	CrCbGaD
Glyburide—ABCC3—lymph node—prostate cancer	0.000233	0.00363	CbGeAlD
Glyburide—SLC15A2—testis—prostate cancer	0.000229	0.00357	CbGeAlD
Glyburide—ABCC1—testis—prostate cancer	0.000226	0.00353	CbGeAlD
Glyburide—ABCG2—bone marrow—prostate cancer	0.000219	0.00342	CbGeAlD
Glyburide—SLCO2B1—lymph node—prostate cancer	0.000217	0.00339	CbGeAlD
Glyburide—Gliclazide—CYP2C19—prostate cancer	0.00021	0.0885	CrCbGaD
Glyburide—ABCB1—prostate gland—prostate cancer	0.00021	0.00327	CbGeAlD
Glyburide—CYP3A4—renal system—prostate cancer	0.000202	0.00315	CbGeAlD
Glyburide—ALB—lymph node—prostate cancer	0.000199	0.0031	CbGeAlD
Glyburide—ABCG2—testis—prostate cancer	0.000187	0.00292	CbGeAlD
Glyburide—ABCC2—lymph node—prostate cancer	0.000186	0.0029	CbGeAlD
Glyburide—ABCB1—seminal vesicle—prostate cancer	0.000177	0.00277	CbGeAlD
Glyburide—SLC15A2—lymph node—prostate cancer	0.000166	0.00259	CbGeAlD
Glyburide—Bezafibrate—CYP1A1—prostate cancer	0.000164	0.0692	CrCbGaD
Glyburide—ABCC1—lymph node—prostate cancer	0.000164	0.00256	CbGeAlD
Glyburide—Chlorpropamide—CYP2C19—prostate cancer	0.000164	0.0688	CrCbGaD
Glyburide—Zafirlukast—CYP3A4—prostate cancer	0.000155	0.0654	CrCbGaD
Glyburide—ABCB1—epithelium—prostate cancer	0.000154	0.0024	CbGeAlD
Glyburide—Glipizide—CYP3A4—prostate cancer	0.000144	0.0606	CrCbGaD
Glyburide—ABCB1—renal system—prostate cancer	0.000143	0.00223	CbGeAlD
Glyburide—ABCB1—urethra—prostate cancer	0.00014	0.00219	CbGeAlD
Glyburide—ABCG2—lymph node—prostate cancer	0.000136	0.00212	CbGeAlD
Glyburide—ABCB1—bone marrow—prostate cancer	0.000108	0.00168	CbGeAlD
Glyburide—Bezafibrate—CYP3A4—prostate cancer	0.000105	0.0442	CrCbGaD
Glyburide—ABCB1—testis—prostate cancer	9.23e-05	0.00144	CbGeAlD
Glyburide—Gastrointestinal pain—Estradiol—prostate cancer	7.95e-05	0.000737	CcSEcCtD
Glyburide—Decreased appetite—Mitoxantrone—prostate cancer	7.88e-05	0.00073	CcSEcCtD
Glyburide—Vomiting—Goserelin—prostate cancer	7.8e-05	0.000723	CcSEcCtD
Glyburide—Alopecia—Docetaxel—prostate cancer	7.79e-05	0.000722	CcSEcCtD
Glyburide—Rash—Goserelin—prostate cancer	7.73e-05	0.000717	CcSEcCtD
Glyburide—Dermatitis—Goserelin—prostate cancer	7.73e-05	0.000716	CcSEcCtD
Glyburide—Vomiting—Conjugated Estrogens—prostate cancer	7.73e-05	0.000716	CcSEcCtD
Glyburide—Urticaria—Estradiol—prostate cancer	7.73e-05	0.000716	CcSEcCtD
Glyburide—Abdominal pain—Estradiol—prostate cancer	7.69e-05	0.000713	CcSEcCtD
Glyburide—Headache—Goserelin—prostate cancer	7.68e-05	0.000712	CcSEcCtD
Glyburide—Erythema—Docetaxel—prostate cancer	7.67e-05	0.000711	CcSEcCtD
Glyburide—Malnutrition—Docetaxel—prostate cancer	7.67e-05	0.000711	CcSEcCtD
Glyburide—Rash—Conjugated Estrogens—prostate cancer	7.66e-05	0.00071	CcSEcCtD
Glyburide—Dermatitis—Conjugated Estrogens—prostate cancer	7.65e-05	0.00071	CcSEcCtD
Glyburide—Headache—Conjugated Estrogens—prostate cancer	7.61e-05	0.000706	CcSEcCtD
Glyburide—Confusional state—Etoposide—prostate cancer	7.6e-05	0.000705	CcSEcCtD
Glyburide—Alopecia—Capecitabine—prostate cancer	7.54e-05	0.000699	CcSEcCtD
Glyburide—Abdominal distension—Epirubicin—prostate cancer	7.48e-05	0.000693	CcSEcCtD
Glyburide—Feeling abnormal—Mitoxantrone—prostate cancer	7.47e-05	0.000692	CcSEcCtD
Glyburide—Malnutrition—Capecitabine—prostate cancer	7.43e-05	0.000689	CcSEcCtD
Glyburide—Erythema—Capecitabine—prostate cancer	7.43e-05	0.000689	CcSEcCtD
Glyburide—Gastrointestinal pain—Mitoxantrone—prostate cancer	7.41e-05	0.000687	CcSEcCtD
Glyburide—Thrombocytopenia—Etoposide—prostate cancer	7.38e-05	0.000684	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—prostate cancer	7.36e-05	0.000682	CcSEcCtD
Glyburide—Nausea—Goserelin—prostate cancer	7.29e-05	0.000675	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—prostate cancer	7.29e-05	0.000675	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—prostate cancer	7.28e-05	0.000675	CcSEcCtD
Glyburide—Nausea—Conjugated Estrogens—prostate cancer	7.22e-05	0.000669	CcSEcCtD
Glyburide—Urticaria—Mitoxantrone—prostate cancer	7.2e-05	0.000667	CcSEcCtD
Glyburide—Anorexia—Etoposide—prostate cancer	7.18e-05	0.000666	CcSEcCtD
Glyburide—Hypersensitivity—Estradiol—prostate cancer	7.16e-05	0.000664	CcSEcCtD
Glyburide—Abdominal pain—Mitoxantrone—prostate cancer	7.16e-05	0.000664	CcSEcCtD
Glyburide—Eye disorder—Prednisone—prostate cancer	7.11e-05	0.000659	CcSEcCtD
Glyburide—Anaemia—Docetaxel—prostate cancer	7.09e-05	0.000658	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—prostate cancer	7.06e-05	0.000654	CcSEcCtD
Glyburide—Hypotension—Etoposide—prostate cancer	7.04e-05	0.000653	CcSEcCtD
Glyburide—Vision blurred—Capecitabine—prostate cancer	7e-05	0.000649	CcSEcCtD
Glyburide—Asthenia—Estradiol—prostate cancer	6.98e-05	0.000647	CcSEcCtD
Glyburide—Tremor—Capecitabine—prostate cancer	6.96e-05	0.000645	CcSEcCtD
Glyburide—Abdominal distension—Doxorubicin—prostate cancer	6.92e-05	0.000642	CcSEcCtD
Glyburide—Pruritus—Estradiol—prostate cancer	6.88e-05	0.000638	CcSEcCtD
Glyburide—Leukopenia—Docetaxel—prostate cancer	6.87e-05	0.000637	CcSEcCtD
Glyburide—Anaemia—Capecitabine—prostate cancer	6.87e-05	0.000637	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—prostate cancer	6.81e-05	0.000631	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—prostate cancer	6.78e-05	0.000629	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—prostate cancer	6.77e-05	0.000627	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—prostate cancer	6.74e-05	0.000625	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—prostate cancer	6.72e-05	0.000623	CcSEcCtD
Glyburide—Alopecia—Prednisone—prostate cancer	6.72e-05	0.000623	CcSEcCtD
Glyburide—ABCB1—lymph node—prostate cancer	6.69e-05	0.00104	CbGeAlD
Glyburide—Hypersensitivity—Mitoxantrone—prostate cancer	6.68e-05	0.000619	CcSEcCtD
Glyburide—Diarrhoea—Estradiol—prostate cancer	6.65e-05	0.000617	CcSEcCtD
Glyburide—Leukopenia—Capecitabine—prostate cancer	6.65e-05	0.000617	CcSEcCtD
Glyburide—Convulsion—Docetaxel—prostate cancer	6.65e-05	0.000616	CcSEcCtD
Glyburide—Malnutrition—Prednisone—prostate cancer	6.62e-05	0.000614	CcSEcCtD
Glyburide—Erythema—Prednisone—prostate cancer	6.62e-05	0.000614	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—prostate cancer	6.55e-05	0.000607	CcSEcCtD
Glyburide—Arthralgia—Docetaxel—prostate cancer	6.53e-05	0.000606	CcSEcCtD
Glyburide—Myalgia—Docetaxel—prostate cancer	6.53e-05	0.000606	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—prostate cancer	6.53e-05	0.000605	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—prostate cancer	6.51e-05	0.000603	CcSEcCtD
Glyburide—Asthenia—Mitoxantrone—prostate cancer	6.5e-05	0.000603	CcSEcCtD
Glyburide—Jaundice—Epirubicin—prostate cancer	6.46e-05	0.000599	CcSEcCtD
Glyburide—Arthralgia—Capecitabine—prostate cancer	6.33e-05	0.000586	CcSEcCtD
Glyburide—Myalgia—Capecitabine—prostate cancer	6.33e-05	0.000586	CcSEcCtD
Glyburide—Confusional state—Docetaxel—prostate cancer	6.32e-05	0.000585	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—prostate cancer	6.27e-05	0.000582	CcSEcCtD
Glyburide—Oedema—Docetaxel—prostate cancer	6.26e-05	0.000581	CcSEcCtD
Glyburide—Vision blurred—Prednisone—prostate cancer	6.24e-05	0.000578	CcSEcCtD
Glyburide—Feeling abnormal—Etoposide—prostate cancer	6.21e-05	0.000576	CcSEcCtD
Glyburide—Diarrhoea—Mitoxantrone—prostate cancer	6.2e-05	0.000575	CcSEcCtD
Glyburide—Vomiting—Estradiol—prostate cancer	6.18e-05	0.000573	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—prostate cancer	6.18e-05	0.000573	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—prostate cancer	6.16e-05	0.000571	CcSEcCtD
Glyburide—Shock—Docetaxel—prostate cancer	6.16e-05	0.000571	CcSEcCtD
Glyburide—Nervous system disorder—Docetaxel—prostate cancer	6.14e-05	0.000569	CcSEcCtD
Glyburide—Thrombocytopenia—Docetaxel—prostate cancer	6.13e-05	0.000569	CcSEcCtD
Glyburide—Rash—Estradiol—prostate cancer	6.13e-05	0.000568	CcSEcCtD
Glyburide—Dermatitis—Estradiol—prostate cancer	6.13e-05	0.000568	CcSEcCtD
Glyburide—Anaemia—Prednisone—prostate cancer	6.12e-05	0.000567	CcSEcCtD
Glyburide—Confusional state—Capecitabine—prostate cancer	6.11e-05	0.000567	CcSEcCtD
Glyburide—Headache—Estradiol—prostate cancer	6.09e-05	0.000565	CcSEcCtD
Glyburide—Oedema—Capecitabine—prostate cancer	6.06e-05	0.000562	CcSEcCtD
Glyburide—Angioedema—Prednisone—prostate cancer	6.05e-05	0.000561	CcSEcCtD
Glyburide—Urticaria—Etoposide—prostate cancer	5.99e-05	0.000555	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—prostate cancer	5.97e-05	0.000554	CcSEcCtD
Glyburide—Anorexia—Docetaxel—prostate cancer	5.97e-05	0.000553	CcSEcCtD
Glyburide—Shock—Capecitabine—prostate cancer	5.97e-05	0.000553	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—prostate cancer	5.96e-05	0.000552	CcSEcCtD
Glyburide—Nervous system disorder—Capecitabine—prostate cancer	5.95e-05	0.000551	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—prostate cancer	5.95e-05	0.000551	CcSEcCtD
Glyburide—Thrombocytopenia—Capecitabine—prostate cancer	5.94e-05	0.00055	CcSEcCtD
Glyburide—Hyperhidrosis—Capecitabine—prostate cancer	5.86e-05	0.000543	CcSEcCtD
Glyburide—Hypotension—Docetaxel—prostate cancer	5.85e-05	0.000543	CcSEcCtD
Glyburide—Anorexia—Capecitabine—prostate cancer	5.78e-05	0.000536	CcSEcCtD
Glyburide—Nausea—Estradiol—prostate cancer	5.78e-05	0.000535	CcSEcCtD
Glyburide—Vomiting—Mitoxantrone—prostate cancer	5.76e-05	0.000534	CcSEcCtD
Glyburide—Convulsion—Prednisone—prostate cancer	5.73e-05	0.000532	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—prostate cancer	5.73e-05	0.000531	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—prostate cancer	5.72e-05	0.00053	CcSEcCtD
Glyburide—Rash—Mitoxantrone—prostate cancer	5.71e-05	0.00053	CcSEcCtD
Glyburide—Dermatitis—Mitoxantrone—prostate cancer	5.71e-05	0.000529	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.71e-05	0.000529	CcSEcCtD
Glyburide—Headache—Mitoxantrone—prostate cancer	5.68e-05	0.000526	CcSEcCtD
Glyburide—Hypotension—Capecitabine—prostate cancer	5.67e-05	0.000525	CcSEcCtD
Glyburide—Myalgia—Prednisone—prostate cancer	5.63e-05	0.000522	CcSEcCtD
Glyburide—Arthralgia—Prednisone—prostate cancer	5.63e-05	0.000522	CcSEcCtD
Glyburide—Paraesthesia—Docetaxel—prostate cancer	5.62e-05	0.000521	CcSEcCtD
Glyburide—Dyspnoea—Docetaxel—prostate cancer	5.58e-05	0.000518	CcSEcCtD
Glyburide—Eye disorder—Epirubicin—prostate cancer	5.56e-05	0.000515	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—prostate cancer	5.55e-05	0.000515	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.52e-05	0.000512	CcSEcCtD
Glyburide—Dyspepsia—Docetaxel—prostate cancer	5.51e-05	0.000511	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—prostate cancer	5.5e-05	0.00051	CcSEcCtD
Glyburide—Paraesthesia—Capecitabine—prostate cancer	5.45e-05	0.000505	CcSEcCtD
Glyburide—Decreased appetite—Docetaxel—prostate cancer	5.44e-05	0.000505	CcSEcCtD
Glyburide—Gastrointestinal disorder—Docetaxel—prostate cancer	5.41e-05	0.000501	CcSEcCtD
Glyburide—Asthenia—Etoposide—prostate cancer	5.41e-05	0.000501	CcSEcCtD
Glyburide—Dyspnoea—Capecitabine—prostate cancer	5.41e-05	0.000501	CcSEcCtD
Glyburide—Oedema—Prednisone—prostate cancer	5.4e-05	0.000501	CcSEcCtD
Glyburide—Nausea—Mitoxantrone—prostate cancer	5.38e-05	0.000499	CcSEcCtD
Glyburide—Dyspepsia—Capecitabine—prostate cancer	5.34e-05	0.000495	CcSEcCtD
Glyburide—Pruritus—Etoposide—prostate cancer	5.33e-05	0.000494	CcSEcCtD
Glyburide—Shock—Prednisone—prostate cancer	5.31e-05	0.000493	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—prostate cancer	5.3e-05	0.000492	CcSEcCtD
Glyburide—Nervous system disorder—Prednisone—prostate cancer	5.3e-05	0.000491	CcSEcCtD
Glyburide—Decreased appetite—Capecitabine—prostate cancer	5.27e-05	0.000489	CcSEcCtD
Glyburide—Alopecia—Epirubicin—prostate cancer	5.25e-05	0.000487	CcSEcCtD
Glyburide—Gastrointestinal disorder—Capecitabine—prostate cancer	5.24e-05	0.000485	CcSEcCtD
Glyburide—Hyperhidrosis—Prednisone—prostate cancer	5.22e-05	0.000484	CcSEcCtD
Glyburide—Erythema—Epirubicin—prostate cancer	5.18e-05	0.00048	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—prostate cancer	5.18e-05	0.00048	CcSEcCtD
Glyburide—Feeling abnormal—Docetaxel—prostate cancer	5.16e-05	0.000479	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—prostate cancer	5.16e-05	0.000478	CcSEcCtD
Glyburide—Anorexia—Prednisone—prostate cancer	5.15e-05	0.000477	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—prostate cancer	5.14e-05	0.000477	CcSEcCtD
Glyburide—Gastrointestinal pain—Docetaxel—prostate cancer	5.12e-05	0.000475	CcSEcCtD
Glyburide—Feeling abnormal—Capecitabine—prostate cancer	5e-05	0.000463	CcSEcCtD
Glyburide—Gastrointestinal pain—Capecitabine—prostate cancer	4.96e-05	0.00046	CcSEcCtD
Glyburide—Abdominal pain—Docetaxel—prostate cancer	4.95e-05	0.000459	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Prednisone—prostate cancer	4.92e-05	0.000456	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—prostate cancer	4.88e-05	0.000452	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—prostate cancer	4.86e-05	0.000451	CcSEcCtD
Glyburide—Paraesthesia—Prednisone—prostate cancer	4.85e-05	0.00045	CcSEcCtD
Glyburide—Urticaria—Capecitabine—prostate cancer	4.82e-05	0.000447	CcSEcCtD
Glyburide—Abdominal pain—Capecitabine—prostate cancer	4.79e-05	0.000444	CcSEcCtD
Glyburide—Vomiting—Etoposide—prostate cancer	4.79e-05	0.000444	CcSEcCtD
Glyburide—Erythema—Doxorubicin—prostate cancer	4.79e-05	0.000444	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—prostate cancer	4.79e-05	0.000444	CcSEcCtD
Glyburide—Anaemia—Epirubicin—prostate cancer	4.78e-05	0.000444	CcSEcCtD
Glyburide—Dyspepsia—Prednisone—prostate cancer	4.75e-05	0.000441	CcSEcCtD
Glyburide—Rash—Etoposide—prostate cancer	4.75e-05	0.000441	CcSEcCtD
Glyburide—Dermatitis—Etoposide—prostate cancer	4.75e-05	0.00044	CcSEcCtD
Glyburide—Headache—Etoposide—prostate cancer	4.72e-05	0.000438	CcSEcCtD
Glyburide—Decreased appetite—Prednisone—prostate cancer	4.7e-05	0.000435	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—prostate cancer	4.63e-05	0.00043	CcSEcCtD
Glyburide—Hypersensitivity—Docetaxel—prostate cancer	4.61e-05	0.000428	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—prostate cancer	4.51e-05	0.000418	CcSEcCtD
Glyburide—Asthenia—Docetaxel—prostate cancer	4.49e-05	0.000417	CcSEcCtD
Glyburide—Convulsion—Epirubicin—prostate cancer	4.48e-05	0.000416	CcSEcCtD
Glyburide—Nausea—Etoposide—prostate cancer	4.48e-05	0.000415	CcSEcCtD
Glyburide—Hypersensitivity—Capecitabine—prostate cancer	4.47e-05	0.000414	CcSEcCtD
Glyburide—Feeling abnormal—Prednisone—prostate cancer	4.45e-05	0.000413	CcSEcCtD
Glyburide—Pruritus—Docetaxel—prostate cancer	4.43e-05	0.000411	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—prostate cancer	4.43e-05	0.00041	CcSEcCtD
Glyburide—Gastrointestinal pain—Prednisone—prostate cancer	4.42e-05	0.000409	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—prostate cancer	4.41e-05	0.000409	CcSEcCtD
Glyburide—Myalgia—Epirubicin—prostate cancer	4.41e-05	0.000409	CcSEcCtD
Glyburide—Asthenia—Capecitabine—prostate cancer	4.35e-05	0.000403	CcSEcCtD
Glyburide—Urticaria—Prednisone—prostate cancer	4.29e-05	0.000398	CcSEcCtD
Glyburide—Pruritus—Capecitabine—prostate cancer	4.29e-05	0.000398	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—prostate cancer	4.29e-05	0.000397	CcSEcCtD
Glyburide—Diarrhoea—Docetaxel—prostate cancer	4.29e-05	0.000397	CcSEcCtD
Glyburide—Abdominal pain—Prednisone—prostate cancer	4.27e-05	0.000396	CcSEcCtD
Glyburide—Confusional state—Epirubicin—prostate cancer	4.26e-05	0.000395	CcSEcCtD
Glyburide—Oedema—Epirubicin—prostate cancer	4.22e-05	0.000392	CcSEcCtD
Glyburide—Shock—Epirubicin—prostate cancer	4.16e-05	0.000385	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—prostate cancer	4.15e-05	0.000385	CcSEcCtD
Glyburide—Diarrhoea—Capecitabine—prostate cancer	4.15e-05	0.000385	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—prostate cancer	4.14e-05	0.000384	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—prostate cancer	4.14e-05	0.000383	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—prostate cancer	4.08e-05	0.000379	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—prostate cancer	4.08e-05	0.000378	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—prostate cancer	4.08e-05	0.000378	CcSEcCtD
Glyburide—Anorexia—Epirubicin—prostate cancer	4.03e-05	0.000373	CcSEcCtD
Glyburide—Vomiting—Docetaxel—prostate cancer	3.98e-05	0.000369	CcSEcCtD
Glyburide—Hypersensitivity—Prednisone—prostate cancer	3.98e-05	0.000369	CcSEcCtD
Glyburide—Rash—Docetaxel—prostate cancer	3.95e-05	0.000366	CcSEcCtD
Glyburide—Hypotension—Epirubicin—prostate cancer	3.95e-05	0.000366	CcSEcCtD
Glyburide—Dermatitis—Docetaxel—prostate cancer	3.95e-05	0.000366	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—prostate cancer	3.94e-05	0.000365	CcSEcCtD
Glyburide—Headache—Docetaxel—prostate cancer	3.92e-05	0.000364	CcSEcCtD
Glyburide—Oedema—Doxorubicin—prostate cancer	3.91e-05	0.000362	CcSEcCtD
Glyburide—Asthenia—Prednisone—prostate cancer	3.88e-05	0.000359	CcSEcCtD
Glyburide—Vomiting—Capecitabine—prostate cancer	3.86e-05	0.000357	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.85e-05	0.000357	CcSEcCtD
Glyburide—Shock—Doxorubicin—prostate cancer	3.85e-05	0.000357	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—prostate cancer	3.83e-05	0.000355	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—prostate cancer	3.83e-05	0.000355	CcSEcCtD
Glyburide—Rash—Capecitabine—prostate cancer	3.82e-05	0.000354	CcSEcCtD
Glyburide—Pruritus—Prednisone—prostate cancer	3.82e-05	0.000354	CcSEcCtD
Glyburide—Dermatitis—Capecitabine—prostate cancer	3.82e-05	0.000354	CcSEcCtD
Glyburide—Headache—Capecitabine—prostate cancer	3.8e-05	0.000352	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—prostate cancer	3.79e-05	0.000352	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—prostate cancer	3.78e-05	0.00035	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—prostate cancer	3.77e-05	0.000349	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—prostate cancer	3.73e-05	0.000345	CcSEcCtD
Glyburide—Nausea—Docetaxel—prostate cancer	3.72e-05	0.000345	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—prostate cancer	3.72e-05	0.000345	CcSEcCtD
Glyburide—Diarrhoea—Prednisone—prostate cancer	3.7e-05	0.000343	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—prostate cancer	3.67e-05	0.00034	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—prostate cancer	3.65e-05	0.000339	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—prostate cancer	3.65e-05	0.000338	CcSEcCtD
Glyburide—Nausea—Capecitabine—prostate cancer	3.6e-05	0.000334	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.56e-05	0.00033	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—prostate cancer	3.51e-05	0.000325	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—prostate cancer	3.48e-05	0.000323	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—prostate cancer	3.48e-05	0.000323	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—prostate cancer	3.45e-05	0.00032	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—prostate cancer	3.44e-05	0.000319	CcSEcCtD
Glyburide—Vomiting—Prednisone—prostate cancer	3.43e-05	0.000318	CcSEcCtD
Glyburide—Rash—Prednisone—prostate cancer	3.41e-05	0.000316	CcSEcCtD
Glyburide—Dermatitis—Prednisone—prostate cancer	3.4e-05	0.000315	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—prostate cancer	3.4e-05	0.000315	CcSEcCtD
Glyburide—Headache—Prednisone—prostate cancer	3.38e-05	0.000314	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.37e-05	0.000313	CcSEcCtD
Glyburide—Urticaria—Epirubicin—prostate cancer	3.36e-05	0.000311	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—prostate cancer	3.34e-05	0.00031	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—prostate cancer	3.22e-05	0.000299	CcSEcCtD
Glyburide—Nausea—Prednisone—prostate cancer	3.21e-05	0.000297	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—prostate cancer	3.2e-05	0.000296	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—prostate cancer	3.11e-05	0.000289	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—prostate cancer	3.11e-05	0.000288	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—prostate cancer	3.09e-05	0.000286	CcSEcCtD
Glyburide—Asthenia—Epirubicin—prostate cancer	3.03e-05	0.000281	CcSEcCtD
Glyburide—Pruritus—Epirubicin—prostate cancer	2.99e-05	0.000277	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—prostate cancer	2.89e-05	0.000268	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—prostate cancer	2.88e-05	0.000267	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—prostate cancer	2.8e-05	0.00026	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—prostate cancer	2.77e-05	0.000256	CcSEcCtD
Glyburide—Vomiting—Epirubicin—prostate cancer	2.69e-05	0.000249	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—prostate cancer	2.67e-05	0.000248	CcSEcCtD
Glyburide—Rash—Epirubicin—prostate cancer	2.66e-05	0.000247	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—prostate cancer	2.66e-05	0.000247	CcSEcCtD
Glyburide—Headache—Epirubicin—prostate cancer	2.65e-05	0.000245	CcSEcCtD
Glyburide—Nausea—Epirubicin—prostate cancer	2.51e-05	0.000233	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—prostate cancer	2.49e-05	0.00023	CcSEcCtD
Glyburide—Rash—Doxorubicin—prostate cancer	2.46e-05	0.000228	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—prostate cancer	2.46e-05	0.000228	CcSEcCtD
Glyburide—Headache—Doxorubicin—prostate cancer	2.45e-05	0.000227	CcSEcCtD
Glyburide—Nausea—Doxorubicin—prostate cancer	2.32e-05	0.000215	CcSEcCtD
Glyburide—ABCC1—Metabolism—PIK3CD—prostate cancer	1.73e-06	1.56e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.72e-06	1.56e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—NCOA1—prostate cancer	1.71e-06	1.55e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP2E1—prostate cancer	1.7e-06	1.54e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SLC5A5—prostate cancer	1.7e-06	1.53e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP19A1—prostate cancer	1.69e-06	1.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TBXAS1—prostate cancer	1.69e-06	1.52e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA4—prostate cancer	1.69e-06	1.52e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—prostate cancer	1.69e-06	1.52e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NQO1—prostate cancer	1.68e-06	1.52e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CB—prostate cancer	1.67e-06	1.51e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOA2—prostate cancer	1.67e-06	1.5e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EP300—prostate cancer	1.66e-06	1.5e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP2E1—prostate cancer	1.66e-06	1.5e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—prostate cancer	1.66e-06	1.5e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TH—prostate cancer	1.66e-06	1.5e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTGS2—prostate cancer	1.66e-06	1.5e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—EP300—prostate cancer	1.65e-06	1.49e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.65e-06	1.49e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA2—prostate cancer	1.65e-06	1.49e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NQO1—prostate cancer	1.64e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP3A4—prostate cancer	1.64e-06	1.48e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—INS—prostate cancer	1.64e-06	1.48e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.63e-06	1.47e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—NOS3—prostate cancer	1.63e-06	1.47e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—RXRA—prostate cancer	1.63e-06	1.47e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SULT1A1—prostate cancer	1.63e-06	1.47e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ABCG5—prostate cancer	1.63e-06	1.47e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TH—prostate cancer	1.62e-06	1.46e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—SRC—prostate cancer	1.62e-06	1.46e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1B1—prostate cancer	1.61e-06	1.46e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CREBBP—prostate cancer	1.6e-06	1.45e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP3A4—prostate cancer	1.6e-06	1.45e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—prostate cancer	1.59e-06	1.44e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SLC5A5—prostate cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTA1—prostate cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.59e-06	1.43e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—EP300—prostate cancer	1.58e-06	1.43e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1B1—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—COMT—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTO1—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NAT2—prostate cancer	1.57e-06	1.42e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTP1—prostate cancer	1.56e-06	1.41e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GGT1—prostate cancer	1.56e-06	1.41e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1A—prostate cancer	1.56e-06	1.41e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—prostate cancer	1.55e-06	1.4e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP2E1—prostate cancer	1.55e-06	1.4e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—prostate cancer	1.55e-06	1.4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NCOA1—prostate cancer	1.54e-06	1.39e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ITPR1—prostate cancer	1.54e-06	1.39e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NQO1—prostate cancer	1.53e-06	1.38e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GGT1—prostate cancer	1.53e-06	1.38e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CD—prostate cancer	1.52e-06	1.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP19A1—prostate cancer	1.52e-06	1.37e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.51e-06	1.37e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TH—prostate cancer	1.51e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PLCB2—prostate cancer	1.51e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.51e-06	1.36e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CB—prostate cancer	1.51e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LRP2—prostate cancer	1.51e-06	1.36e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.5e-06	1.36e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NCOA1—prostate cancer	1.5e-06	1.36e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—prostate cancer	1.5e-06	1.35e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP3A4—prostate cancer	1.5e-06	1.35e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTGS2—prostate cancer	1.49e-06	1.35e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.49e-06	1.34e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EP300—prostate cancer	1.48e-06	1.34e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP19A1—prostate cancer	1.48e-06	1.34e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—P4HB—prostate cancer	1.48e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.47e-06	1.33e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—RXRA—prostate cancer	1.46e-06	1.32e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—TYMS—prostate cancer	1.45e-06	1.31e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—prostate cancer	1.45e-06	1.3e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TGFB1—prostate cancer	1.44e-06	1.3e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—SRC—prostate cancer	1.44e-06	1.3e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—GSTM1—prostate cancer	1.44e-06	1.3e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.44e-06	1.3e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—NOS3—prostate cancer	1.44e-06	1.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—RXRA—prostate cancer	1.43e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GGT1—prostate cancer	1.42e-06	1.29e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.42e-06	1.29e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—LPL—prostate cancer	1.41e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—COMT—prostate cancer	1.41e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTP1—prostate cancer	1.4e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NCOA1—prostate cancer	1.4e-06	1.27e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.4e-06	1.26e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—STAT3—prostate cancer	1.39e-06	1.25e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.38e-06	1.25e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ITPR1—prostate cancer	1.38e-06	1.25e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—EP300—prostate cancer	1.38e-06	1.24e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MED12—prostate cancer	1.38e-06	1.24e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—COMT—prostate cancer	1.38e-06	1.24e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTP1—prostate cancer	1.37e-06	1.24e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GNG5—prostate cancer	1.37e-06	1.23e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP1A1—prostate cancer	1.36e-06	1.23e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.36e-06	1.23e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—ERCC2—prostate cancer	1.35e-06	1.22e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ITPR1—prostate cancer	1.35e-06	1.22e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—prostate cancer	1.34e-06	1.21e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—RXRA—prostate cancer	1.33e-06	1.2e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CB—prostate cancer	1.32e-06	1.2e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA3—prostate cancer	1.32e-06	1.19e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTGS2—prostate cancer	1.31e-06	1.18e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—TYMS—prostate cancer	1.3e-06	1.18e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—prostate cancer	1.3e-06	1.17e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.3e-06	1.17e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—MYC—prostate cancer	1.29e-06	1.17e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—GSTM1—prostate cancer	1.29e-06	1.16e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—TGFB1—prostate cancer	1.29e-06	1.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—COMT—prostate cancer	1.29e-06	1.16e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTP1—prostate cancer	1.28e-06	1.16e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—TYMS—prostate cancer	1.27e-06	1.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—prostate cancer	1.27e-06	1.15e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—LPL—prostate cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EGFR—prostate cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—prostate cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ITPR1—prostate cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—GSTM1—prostate cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—HPGDS—prostate cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.25e-06	1.13e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PPARA—prostate cancer	1.25e-06	1.12e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—EP300—prostate cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—LPL—prostate cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—prostate cancer	1.23e-06	1.11e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—prostate cancer	1.22e-06	1.11e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTT1—prostate cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ACHE—prostate cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—ERCC2—prostate cancer	1.21e-06	1.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP1A1—prostate cancer	1.19e-06	1.08e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—prostate cancer	1.19e-06	1.08e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—TYMS—prostate cancer	1.19e-06	1.07e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—prostate cancer	1.19e-06	1.07e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—ERCC2—prostate cancer	1.18e-06	1.07e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—GSTM1—prostate cancer	1.18e-06	1.06e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—prostate cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—CAV1—prostate cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PRKACB—prostate cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—LPL—prostate cancer	1.15e-06	1.04e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.15e-06	1.04e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—prostate cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—prostate cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PPARA—prostate cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—prostate cancer	1.11e-06	1e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—ERCC2—prostate cancer	1.11e-06	9.98e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA2—prostate cancer	1.1e-06	9.91e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—prostate cancer	1.1e-06	9.89e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—EP300—prostate cancer	1.09e-06	9.85e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PPARA—prostate cancer	1.09e-06	9.85e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CG—prostate cancer	1.07e-06	9.63e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CAV1—prostate cancer	1.05e-06	9.49e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.05e-06	9.46e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—prostate cancer	1.04e-06	9.38e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CAV1—prostate cancer	1.03e-06	9.26e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.02e-06	9.24e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.02e-06	9.21e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PPARA—prostate cancer	1.02e-06	9.2e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NQO1—prostate cancer	1.01e-06	9.13e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—INS—prostate cancer	1.01e-06	9.12e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1e-06	9.07e-06	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—prostate cancer	1e-06	9.06e-06	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—prostate cancer	9.98e-07	9.01e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TH—prostate cancer	9.97e-07	9e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—CREBBP—prostate cancer	9.89e-07	8.93e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—IL6—prostate cancer	9.7e-07	8.76e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1B1—prostate cancer	9.7e-07	8.76e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CAV1—prostate cancer	9.59e-07	8.65e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CG—prostate cancer	9.58e-07	8.64e-06	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—prostate cancer	9.57e-07	8.64e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GGT1—prostate cancer	9.4e-07	8.48e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CD—prostate cancer	9.38e-07	8.47e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CG—prostate cancer	9.35e-07	8.44e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NCOA1—prostate cancer	9.26e-07	8.35e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—prostate cancer	9.18e-07	8.28e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	9.16e-07	8.27e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP19A1—prostate cancer	9.12e-07	8.23e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—INS—prostate cancer	9.07e-07	8.18e-06	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—prostate cancer	8.95e-07	8.08e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CREBBP—prostate cancer	8.88e-07	8.01e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—NOS3—prostate cancer	8.86e-07	7.99e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—INS—prostate cancer	8.85e-07	7.99e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RXRA—prostate cancer	8.8e-07	7.95e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CG—prostate cancer	8.73e-07	7.88e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CREBBP—prostate cancer	8.67e-07	7.82e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—COMT—prostate cancer	8.48e-07	7.65e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTP1—prostate cancer	8.44e-07	7.62e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CD—prostate cancer	8.42e-07	7.6e-06	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—prostate cancer	8.33e-07	7.52e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ITPR1—prostate cancer	8.3e-07	7.5e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—INS—prostate cancer	8.27e-07	7.46e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CD—prostate cancer	8.22e-07	7.42e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CB—prostate cancer	8.17e-07	7.38e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTGS2—prostate cancer	8.1e-07	7.31e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CREBBP—prostate cancer	8.1e-07	7.31e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—prostate cancer	8.08e-07	7.29e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NOS3—prostate cancer	7.95e-07	7.18e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—TYMS—prostate cancer	7.85e-07	7.08e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NOS3—prostate cancer	7.76e-07	7e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—GSTM1—prostate cancer	7.76e-07	7e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CD—prostate cancer	7.68e-07	6.93e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—LPL—prostate cancer	7.61e-07	6.87e-06	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—prostate cancer	7.5e-07	6.77e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP1A1—prostate cancer	7.35e-07	6.64e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CB—prostate cancer	7.34e-07	6.62e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—ERCC2—prostate cancer	7.29e-07	6.58e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTGS2—prostate cancer	7.27e-07	6.56e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NOS3—prostate cancer	7.25e-07	6.54e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CB—prostate cancer	7.16e-07	6.46e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTGS2—prostate cancer	7.1e-07	6.41e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—prostate cancer	7.06e-07	6.38e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—prostate cancer	6.85e-07	6.19e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—EP300—prostate cancer	6.74e-07	6.08e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PPARA—prostate cancer	6.72e-07	6.07e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CB—prostate cancer	6.69e-07	6.04e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTGS2—prostate cancer	6.63e-07	5.98e-06	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—prostate cancer	6.6e-07	5.95e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—prostate cancer	6.34e-07	5.72e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CAV1—prostate cancer	6.32e-07	5.71e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—prostate cancer	6.19e-07	5.59e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—EP300—prostate cancer	6.05e-07	5.46e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—EP300—prostate cancer	5.9e-07	5.33e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—prostate cancer	5.78e-07	5.22e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CG—prostate cancer	5.76e-07	5.2e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—EP300—prostate cancer	5.51e-07	4.98e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—INS—prostate cancer	5.45e-07	4.92e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CREBBP—prostate cancer	5.34e-07	4.82e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CD—prostate cancer	5.06e-07	4.57e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—prostate cancer	4.98e-07	4.5e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NOS3—prostate cancer	4.78e-07	4.32e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—prostate cancer	4.47e-07	4.04e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CB—prostate cancer	4.41e-07	3.98e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTGS2—prostate cancer	4.37e-07	3.95e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—prostate cancer	4.37e-07	3.94e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—prostate cancer	4.08e-07	3.68e-06	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—prostate cancer	4.07e-07	3.67e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—prostate cancer	3.81e-07	3.44e-06	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—prostate cancer	3.65e-07	3.3e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—EP300—prostate cancer	3.64e-07	3.28e-06	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—prostate cancer	3.57e-07	3.22e-06	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—prostate cancer	3.33e-07	3.01e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—prostate cancer	2.69e-07	2.43e-06	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—prostate cancer	2.2e-07	1.98e-06	CbGpPWpGaD
